CL - Colgate-Palmolive Company

NYSE - NYSE Delayed Price. Currency in USD
+0.50 (+0.68%)
At close: 4:02PM EDT

74.50 0.00 (0.00%)
After hours: 5:14PM EDT

Stock chart is not supported by your current browser
Previous Close 74.00
Open 74.21
Bid 74.12 x 1300
Ask 74.58 x 1400
Day's Range 73.96 - 74.64
52 Week Range 57.41 - 75.52
Volume 3,098,390
Avg. Volume 3,209,346
Market Cap 63.959B
Beta (3Y Monthly) 0.82
PE Ratio (TTM) 27.80
Earnings Date N/A
Forward Dividend & Yield 1.72 (2.32%)
Ex-Dividend Date 2019-07-17
1y Target Est N/A
Trade prices are not sourced from all markets
  • Benzinga 5 days ago

    Analyst Breaks Down Colgate's Largest Acquisition Since 1995

    Colgate-Palmolive Company (NYSE: CL ) acquired Laboratories Filorga in a move which will support growth amid global challenges, according to Bank of America. The Analyst Bank of America's Olivia Tong maintains ...

  • Benzinga 5 days ago

    Johnson & Johnson Falls On Report Of Justice Department Probe

    The investigation is focused on whether J&J deceived the public about the risk of cancer linked to its talcum powder, sources told Bloomberg. A grand jury in Washington is examining documents that may shed light as to what company executives knew about the potential dangers of the talc powder, the report said. The Justice Department didn't respond to Bloomberg's request for comment.

  • Colgate (CL) to Expand Skin Care Range With Filorga Buyout
    Zacks 5 days ago

    Colgate (CL) to Expand Skin Care Range With Filorga Buyout

    Colgate (CL) to expand the personal care portfolio with the acquisition of skin care business of France-based Filorga.

  • 5 days ago

    Colgate-Palmolive to Buy Filorga Skin Care Business for $1.69 Billion

    Colgate-Palmolive is buying the skin care business of the French company Laboratoires Filorga Cosmetiques for about $1.69 billion.

  • After Hours: Illumina Issues a Warning, Colgate-Palmolive Makes an Acquisition
    Motley Fool 5 days ago

    After Hours: Illumina Issues a Warning, Colgate-Palmolive Makes an Acquisition

    The DNA sequencing specialist indicates its Q2 revenue won't be as high as previously expected, while the consumer goods giant pushes deeper into the cosmetics segment.

  • Financial Times 5 days ago

    Colgate-Palmolive to buy French skincare business for €1.5bn

    Colgate-Palmolive has reached an agreement to buy the Filorga Cosmétiques skincare business for €1.5bn, a sign the US consumer goods group is turning to deals to diversify its interests beyond toothpaste and soap. Filorga, based in Paris, is an anti-ageing skin care brand focused primarily on facial care. The purchase is notable for Colgate, which despite its size had been reticent over mergers and acquisitions under longtime chief executive Ian Cook.

  • Reuters 6 days ago

    UPDATE 1-Colgate to buy skin care business of France's Filorga for $1.69 bln

    Colgate-Palmolive Co said on Thursday it would buy the skin care unit of France's Laboratoires Filorga Cosmétiques for 1.50 billion euros ($1.69 billion), as the consumer goods company bolsters its personal care business. Filorga's anti-aging skin care products are sold in over 60 countries, with its largest markets being France, Italy, Spain and Greater China. "This acquisition also provides Colgate entry into the fast-growing and sizeable travel retail channel, particularly in Asia," Chief Executive Officer Noel Wallace said.

  • Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins
    Zacks 7 days ago

    Colgate's (CL) Growth Efforts Well on Track Amid Soft Margins

    Colgate's (CL) strong surprise trend, higher pricing, strong innovation and expansion efforts bode well. However, high input costs and currency headwinds concerns.

  • American City Business Journals 8 days ago

    Atlanta Braves director, Kennesaw State VP among Leadership Cobb Class of 2020 (Slideshow)

    The 2019-2020 class of Leadership Cobb is set. The Cobb Chamber on Monday announced the 50 members (26 men, 24 women) of this year's leadership development program that's focused on personal and professional growth.

  • Markit 8 days ago

    See what the IHS Markit Score report has to say about Colgate-Palmolive Co.

    Colgate-Palmolive Co NYSE:CLView full report here! Summary * Perception of the company's creditworthiness is negative * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for CL with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting CL. Money flowETF/Index ownership | NeutralETF activity is neutral. The net inflows of $6.63 billion over the last one-month into ETFs that hold CL are not among the highest of the last year and have been slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | NegativeThe current level displays a negative indicator. CL credit default swap spreads are near their highest levels of the last 3 years, which indicates the market's more negative perception of the company's credit worthiness.Please send all inquiries related to the report to and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Soap & Cleaning Materials Industry Outlook Upbeat on New Products
    Zacks 9 days ago

    Soap & Cleaning Materials Industry Outlook Upbeat on New Products

    Soap & Cleaning Materials Industry Outlook Upbeat on New Products

  • Can Personal Care Players Keep Producing Double-Digit Returns?
    Market Realist 14 days ago

    Can Personal Care Players Keep Producing Double-Digit Returns?

    Shares of most US household and personal care manufacturers generated double-digit returns in the first half. What does the future hold?

  • MarketWatch 15 days ago

    Cannabis sector could grow to $200 billion in a decade, say Stifel analysts

    The cannabis sector offers a $200 billion global opportunity in the next decade, up from the roughly $8 billion that was generated in 2018 in federal legal markets and U.S. state licensed sales, Stifel analysts wrote Tuesday in a new report. Market leader Canopy Growth Corp. disappointed investors with weaker-than-expected earnings last week and mixed outlook, as elevated costs during the current investment phase lowered gross margin forecasts, said the report. "While the near-term execution at Canopy is underwhelming likely driving a portion of the elevated expenses, we remain confident that Canopy is best positioned to tackle all avenues for growth in the $200 billion global category," the analysts led by Andrew Carter wrote in the report. In the same vein, Canada currently represents the most significant near-term opportunity, as the only G-7 country to have fully legalized cannabis last October. Stifel is expecting Canada to achieve C$10 billion in annual sales by 2023. "The market is quickly taking shape with the latest update from Stats Canada suggesting a C$ 900 million annualized market in April with sales in the month up 23% sequentially likely driven by the cannabis enthusiast holiday 4/20 and initial store openings in Ontario," said the report. But Canada sales will be eclipsed by the U.S. which offers a $100 billion opportunity over the next decade, the analysts wrote. That opportunity will change if federal rules are relaxed, which Stifel is expecting is at best a 2021 possibility. "While there has been a flurry of legislation in Congress with a number of items achieving success in the House of Representatives, we believe the political calculus of Senate majority leader Senator Mitch McConnell favors keeping any cannabis legislation from reaching the Senate floor for a vote," they wrote. "While cannabis enjoys bipartisan approval, we contend the issue of change at the federal level is not salient with American voters." The report noted the three companies that are expected to benefit from legalization in Illinois, which last week became the first state to legalize through the state legislature and not through the ballot box. Cresco Labs Inc. , Green Thumb Industries Inc. and PharmaCann, the state's three medical operators, are expected to benefit. The ETFMG Alternative Harvest ETF has gained 29% in 2019 to date, while the S&P 500 has gained 18%.

  • The Top Nike Shareholders (NKE)
    Investopedia 18 days ago

    The Top Nike Shareholders (NKE)

    Learn about the history of Nike Inc. and the top shareholders who continue to benefit from the company's explosive success.

  • 18 days ago

    These 3 Dividend Aristocrats Have Consumable Products as Part of Their Offerings

    When we talk Dividend Aristocrats and Dividend Kings, it should come as little surprise the Kings and their more than 50 years of increasing dividends earns the same as a lot in the Dividend Aristocrats, given they easily satisfy the criteria that is increasing their dividends for at least 25 years. This led me to suggest investors through the Kings for companies that have inelastic and defensible business models. Now let's do the same for the Dividend Aristocrats.

  • Have Insiders Been Selling Colgate-Palmolive Company (NYSE:CL) Shares?
    Simply Wall St. 20 days ago

    Have Insiders Been Selling Colgate-Palmolive Company (NYSE:CL) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...

  • Church & Dwight Continues to Outperform with Its Earnings Growth
    Market Realist 23 days ago

    Church & Dwight Continues to Outperform with Its Earnings Growth

    Church & Dwight’s (CHD) earnings have grown at a strong double-digit rate in the past several quarters and have outpaced those of its rivals. The company has surpassed Wall Street’s expectations in five out of the past six quarters.

  • Why Wall Street Suggests ‘Hold’ for Colgate-Palmolive Stock
    Market Realist 27 days ago

    Why Wall Street Suggests ‘Hold’ for Colgate-Palmolive Stock

    Colgate-Palmolive's (CL) improved organic sales and better-than-expected earnings have boosted its stock in the past two quarters.

  • This Could Continue to Hurt Colgate-Palmolive’s EPS
    Market Realist 28 days ago

    This Could Continue to Hurt Colgate-Palmolive’s EPS

    While Colgate-Palmolive (CL) has beaten Wall Street’s EPS expectations in the past two quarters, its adjusted EPS have fallen in the past three quarters.

  • Colgate-Palmolive’s Revenue Unlikely to Impress
    Market Realist 28 days ago

    Colgate-Palmolive’s Revenue Unlikely to Impress

    Whereas Colgate-Palmolive’s (CL) top line beat analysts' estimate in the first quarter, it has missed their estimates in four of the past five quarters.

  • Procter & Gamble Moves Up the Charts: Will Growth Continue?
    Zacks 28 days ago

    Procter & Gamble Moves Up the Charts: Will Growth Continue?

    Procter & Gamble (PG) emphasizes on improving its product portfolio through strategic initiatives. Also, the company is on track with its cost-saving plans.

  • 29 days ago

    5 Companies Reach Yearly Highs

    Recently, 5 companies have managed to achieve 52-week highs

  • Church & Dwight Sales to Gain on International Unit & More
    Zacks 29 days ago

    Church & Dwight Sales to Gain on International Unit & More

    Church & Dwight's (CHD) top line has been impressive for a while, gaining from strong Consumer International unit, buyouts and innovation.

  • Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?
    Zacks last month

    Newell Loses 22% YTD: Can Its Transformation Plan Aid Stock?

    Newell's (NWL) dismal sales surprise trend can be attributed to lower core sales and adverse foreign currency. Nevertheless, its Transformation Plan appears encouraging.